1. Home
  2. SLNO vs SNDR Comparison

SLNO vs SNDR Comparison

Compare SLNO & SNDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • SNDR
  • Stock Information
  • Founded
  • SLNO 1999
  • SNDR 1935
  • Country
  • SLNO United States
  • SNDR United States
  • Employees
  • SLNO N/A
  • SNDR N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • SNDR Trucking Freight/Courier Services
  • Sector
  • SLNO Health Care
  • SNDR Industrials
  • Exchange
  • SLNO Nasdaq
  • SNDR Nasdaq
  • Market Cap
  • SLNO 3.8B
  • SNDR 4.2B
  • IPO Year
  • SLNO 2014
  • SNDR 2017
  • Fundamental
  • Price
  • SLNO $82.27
  • SNDR $26.95
  • Analyst Decision
  • SLNO Strong Buy
  • SNDR Buy
  • Analyst Count
  • SLNO 9
  • SNDR 14
  • Target Price
  • SLNO $105.11
  • SNDR $27.64
  • AVG Volume (30 Days)
  • SLNO 1.4M
  • SNDR 769.9K
  • Earning Date
  • SLNO 08-06-2025
  • SNDR 07-31-2025
  • Dividend Yield
  • SLNO N/A
  • SNDR 1.41%
  • EPS Growth
  • SLNO N/A
  • SNDR N/A
  • EPS
  • SLNO N/A
  • SNDR 0.71
  • Revenue
  • SLNO N/A
  • SNDR $5,373,300,000.00
  • Revenue This Year
  • SLNO N/A
  • SNDR $10.86
  • Revenue Next Year
  • SLNO N/A
  • SNDR $6.04
  • P/E Ratio
  • SLNO N/A
  • SNDR $37.90
  • Revenue Growth
  • SLNO N/A
  • SNDR N/A
  • 52 Week Low
  • SLNO $41.50
  • SNDR $20.59
  • 52 Week High
  • SLNO $90.32
  • SNDR $33.90
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 51.33
  • SNDR 72.65
  • Support Level
  • SLNO $79.70
  • SNDR $25.16
  • Resistance Level
  • SLNO $90.32
  • SNDR $27.18
  • Average True Range (ATR)
  • SLNO 3.66
  • SNDR 0.69
  • MACD
  • SLNO -0.41
  • SNDR 0.24
  • Stochastic Oscillator
  • SLNO 31.42
  • SNDR 93.72

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About SNDR Schneider National Inc.

Schneider National Inc is a provider of surface transportation and logistics solutions in North America. The Company offers truckload, intermodal, and logistics services to a diverse customer base throughout the continental United States, Canada, and Mexico. The company's segments include Truckload; Intermodal; Logistics and other. It generates maximum revenue from the Truckload segment.

Share on Social Networks: